PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.\', \'Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.\', \'Infectious Diseases, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.\', \'Clinical Chemistry Service, Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.\', \'Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York. Electronic address: gyurkocb@mskcc.org.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S2666-6367(21)01296-310.1016/j.jtct.2021.10.004
?:hasPublicationType
?:journal
  • Transplantation and cellular therapy
is ?:pmid of
?:pmid
?:pmid
  • 34649021
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Hematopoietic Cell Transplantation is Feasible in Patients with Prior COVID-19 Infection.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all